• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
LTP

LTR PHARMA LIMITED - News & Media

24.7% ! 58.0¢
Market Cap $64.93M  !
Healthcare Biotechnology
Add to My Watchlist

LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The... LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is developing and commercializing therapies that address significant unmet medical needs. The Company is focused on improving men’s health through clinical development and commercialization of nasal spray treatments for erectile dysfunction. Its lead products, SPONTAN and ROXUS, are fast-acting intranasal sprays for the treatment of erectile dysfunction, enabling onset of action in 10 minutes or less. The Company is also advancing OROFLOW, a novel intranasal spray under development for the treatment of Oesophageal Motility Disorders (OMD) - a debilitating group of conditions affecting swallowing function. The Company's subsidiary is LTR Pharma Inc.More

Articles & Videos

LTR Pharma dips -6% as US growth plans confuse with two identical products to be launched

LTR Pharma has revealed its latest plan to further expand into the U.S. – with a product, Roxus, it says taps into "personalised healthcare."

26 Mar 2025 13:54 (AEDT)

LTR Pharma pairs with Men's Health Downunder for supply of erectile dysfunction spray

LTR Pharma Ltd has signed an agreement with Men's Health Downunder to facilitate supply of its lead nasal spray SPONTAN

19 Dec 2024 09:37 (AEDT)

LTR Pharma launches mix of online e-store, telehealth service to boost prescriptions

LTR Pharma has launched an online 'men's health platform' to "facilitate the regulated prescription" of its nasal spray viagra product.

12 Dec 2024 10:54 (AEDT)

LTR Pharma's SPONTAN 'nasal viagra' absorbed 470% times faster than oral solution

LTR Pharma (ASX:LTP) has posted final study results showing its 'nasal viagra' drug SPONTAN is absorbed 470% faster than oral tablets.

14 Oct 2024 09:28 (AEDT)

'Nasal spray viagra' company LTR Pharma jumps 8% on second prescription under TGA access scheme

LTR Pharma (ASX:LTP) has announced its nasal spray 'viagra drug' SPONTAN has been prescribed by a Brisbane-based men's health expert under the drug regulator's Special Access Scheme (SAS).

08 Aug 2024 12:06 (AEST)

LTR Pharma doses first patient with SPONTAN viagra nasal spray via TGA

Australia's healthcare regulator TGA has enabled LTR Pharma (ASX:LTP) to dose the first patient with viagra nasal spray product SPONTAN.

05 Aug 2024 09:18 (AEST)

LTR Pharma rises 58% on fast-acting erectile dysfunction nasal spray success

LTR Pharma (ASX:LTP) – a recent ASX listee developing a viagra-like nasal spray – has rocketed +48% on Friday after positive trial results.

07 Jun 2024 13:03 (AEST)



Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
58.0¢ 		Change
0.115(24.7%) 		Mkt cap ! $64.93M
Open High Low Value Volume
47.5¢ 58.0¢ 47.5¢ $1.630M 3.029M

Buyers (Bids)

No. Vol. Price($)
1 27566 58.0¢
 

Sellers (Offers)

Price($) Vol. No.
58.5¢ 35000 1
View Market Depth
Last trade - 16.10pm 12/09/2025 (20 minute delay) ?
Last
57.5¢ 		  Change
0.115 ( 23.7 %)
Open High Low Volume
47.5¢ 57.5¢ 47.5¢ 290511
Last updated 15.59pm 12/09/2025 ?
LTP (ASX) Chart

Top Stories

Afterpay owner Block shares dip after competitor Klarna lists 30% higher out the gate

Afterpay owner Block has seen its shares head towards a -3% drop as the market digests news of Klarna's successful U.S. IPO overnight.
From the 4DS Memory playbook: Boss Energy flags strategic review to sate Honeymoon concerns Boss Energy's era of vicissitudes could be over as the company has now done what some shareholders have been asking - share some clarity.
Market Close: Aussie traders divorce from US as retreat continues. At least there's 4DX Good Afternoon and welcome to HotCopper’s Market Close for Thursday 11th of September, I’m Jon Davidson. We’ve truly diverted from Wall Street at the start of September with the local bourse retreating once again this week, showing an Australian inv...
Perenti's Barminco to keep working with Ramelius after winning $300M Dalgaranga contract Mine services group Perenti has landed a $300M contract through its underground subsidiary, Barminco, to work on the Dalgaranga Gold Project.
Red Mountain the latest to join critical minerals rush in Utah with 87 claims Red Mountain Mining has expanded its U.S. critical minerals portfolio, buying up 87 claims in the state's Antimony Mining District.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.